The Role of Adjuvant Chemotherapy in Management of Stage I Pancreatic Ductal Adenocarcinoma Deserves Independent High Quality Research.

Journal of Hepato-Biliary-Pancreatic SciencesEarly View LETTER TO THE EDITOR The role of adjuvant chemotherapy in management of stage I pancreatic ductal adenocarcinoma deserves independent high quality research Shahin Hajibandeh, Corresponding Author Shahin Hajibandeh [email protected] orcid.org/0000-0001-6159-1068 Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK Department of Hepatobiliary and Pancreatic Surgery, University Hospital Coventry, Coventry, UK Correspondence Shahin Hajibandeh, Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK. Email: [email protected]Search for more papers by this authorShahab Hajibandeh, Shahab Hajibandeh Department of Hepatobiliary and Pancreatic Surgery, University Hospital of Wales, Cardiff, UKSearch for more papers by this authorTejinderjit S. Athwal, Tejinderjit S. Athwal Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UKSearch for more papers by this author Shahin Hajibandeh, Corresponding Author Shahin Hajibandeh [email protected] orcid.org/0000-0001-6159-1068 Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK Department of Hepatobiliary and Pancreatic Surgery, University Hospital Coventry, Coventry, UK Correspondence Shahin Hajibandeh, Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK. Email: [email protected]Search for more papers by this authorShahab Hajibandeh, Shahab Hajibandeh Department of Hepatobiliary and Pancreatic Surgery, University Hospital of Wales, Cardiff, UKSearch for more papers by this authorTejinderjit S. Athwal, Tejinderjit S. Athwal Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UKSearch for more papers by this author First published: 21 December 2023 https://doi.org/10.1002/jhbp.1409Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Kwon W, Heo JS, Han IW, Kang CM, Hwang HK, Kim SC, et al. Features of T1 pancreatic cancer and validation of the eighth edition AJCC staging system definition using a Korean-Japanese joint cohort and the SEER database. J Hepatobiliary Pancreat Sci. 2023; 30(9): 1129–1140. 10.1002/jhbp.1316 PubMedWeb of Science®Google Scholar 2Turner KM, Delman AM, Ammann AM, Sohal D, Olowokure O, Choe KA, et al. Is there a benefit to adjuvant chemotherapy in resected, early stage pancreatic ductal adenocarcinoma? Ann Surg Oncol. 2022; 29: 4610–4619. 10.1245/s10434-022-11580-7 Web of Science®Google Scholar 3Blackford AL, Canto MI, Klein AP, Hruban RH, Goggins M. Recent trends in the incidence and survival of stage 1A pancreatic cancer: a surveillance, epidemiology, and end results analysis. J Natl Cancer Inst. 2020; 112(11): 1162–1169. 10.1093/jnci/djaa004 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation